ABT-199 mediated inhibition of BCL-2 as a novel therapeutic strategy in T-cell acute lymphoblastic leukemia

S Peirs; F Matthijssens; S Goossens; I Van de Walle; K Ruggero; CE de Bock; S Degryse; Kirsten Canté; D Briot; E Clappier; T Lammens; B de Moerloose; Y Benoit; B Poppe; Jules Meijerink; J Cools; J Soulier; TH Rabbitts; T Taghon; F Speleman; P van Vlierberghe

doi:10.1182/blood-2014-05-574566

ABT-199 mediated inhibition of BCL-2 as a novel therapeutic strategy in T-cell acute lymphoblastic leukemia

S Peirs, F Matthijssens, S Goossens, I Van de Walle, K Ruggero, CE de Bock, S Degryse, Kirsten Canté, D Briot, E Clappier, T Lammens, B de Moerloose, Y Benoit, B Poppe, Jules Meijerink, J Cools, J Soulier, TH Rabbitts, T Taghon, F SpelemanP van Vlierberghe

Pediatrics

Research output: Contribution to journal › Article › Academic › peer-review

175 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	3738-3747
Number of pages	10
Journal	Blood
Volume	124
Issue number	25
DOIs	https://doi.org/10.1182/blood-2014-05-574566
Publication status	Published - 2014

Access to Document

10.1182/blood-2014-05-574566

Cite this

Peirs, S., Matthijssens, F., Goossens, S., Van de Walle, I., Ruggero, K., de Bock, CE., Degryse, S., Canté, K., Briot, D., Clappier, E., Lammens, T., de Moerloose, B., Benoit, Y., Poppe, B., Meijerink, J., Cools, J., Soulier, J., Rabbitts, TH., Taghon, T., ... van Vlierberghe, P. (2014). ABT-199 mediated inhibition of BCL-2 as a novel therapeutic strategy in T-cell acute lymphoblastic leukemia. Blood, 124(25), 3738-3747. https://doi.org/10.1182/blood-2014-05-574566

@article{2643f258de34438888cf0fd7609524ce,

title = "ABT-199 mediated inhibition of BCL-2 as a novel therapeutic strategy in T-cell acute lymphoblastic leukemia",

author = "S Peirs and F Matthijssens and S Goossens and {Van de Walle}, I and K Ruggero and {de Bock}, CE and S Degryse and Kirsten Cant{\'e} and D Briot and E Clappier and T Lammens and {de Moerloose}, B and Y Benoit and B Poppe and Jules Meijerink and J Cools and J Soulier and TH Rabbitts and T Taghon and F Speleman and {van Vlierberghe}, P",

year = "2014",

doi = "10.1182/blood-2014-05-574566",

language = "Undefined/Unknown",

volume = "124",

pages = "3738--3747",

journal = "Blood",

issn = "0006-4971",

publisher = "American Society of Hematology",

number = "25",

}

Peirs, S, Matthijssens, F, Goossens, S, Van de Walle, I, Ruggero, K, de Bock, CE, Degryse, S, Canté, K, Briot, D, Clappier, E, Lammens, T, de Moerloose, B, Benoit, Y, Poppe, B, Meijerink, J, Cools, J, Soulier, J, Rabbitts, TH, Taghon, T, Speleman, F & van Vlierberghe, P 2014, 'ABT-199 mediated inhibition of BCL-2 as a novel therapeutic strategy in T-cell acute lymphoblastic leukemia', Blood, vol. 124, no. 25, pp. 3738-3747. https://doi.org/10.1182/blood-2014-05-574566

TY - JOUR

T1 - ABT-199 mediated inhibition of BCL-2 as a novel therapeutic strategy in T-cell acute lymphoblastic leukemia

AU - Peirs, S

AU - Matthijssens, F

AU - Goossens, S

AU - Van de Walle, I

AU - Ruggero, K

AU - de Bock, CE

AU - Degryse, S

AU - Canté, Kirsten

AU - Briot, D

AU - Clappier, E

AU - Lammens, T

AU - de Moerloose, B

AU - Benoit, Y

AU - Poppe, B

AU - Meijerink, Jules

AU - Cools, J

AU - Soulier, J

AU - Rabbitts, TH

AU - Taghon, T

AU - Speleman, F

AU - van Vlierberghe, P

PY - 2014

Y1 - 2014

U2 - 10.1182/blood-2014-05-574566

DO - 10.1182/blood-2014-05-574566

M3 - Article

SN - 0006-4971

VL - 124

SP - 3738

EP - 3747

JO - Blood

JF - Blood

IS - 25

ER -